Quinapril/Hydrochlorothiazide Tablet Shortage
Last Updated: August 19, 2025
Status: Current
Unavailable, Current:
- Accuretic, Tablet, 10 mg/12.5 mg (Pfizer Inc.)
- Accuretic, Tablet, 20 mg/12.5 mg (Pfizer Inc.)
- Accuretic, Tablet, 25 mg/20 mg (Pfizer Inc.)
Discontinued, Current:
- Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (Aurobindo Pharma USA)
- Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (Aurobindo Pharma USA)
- Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (Aurobindo Pharma USA)
Available, Current:
- Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (Chartwell Molecular Holdings LLC)
- Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (Chartwell Molecular Holdings LLC)
- Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (Chartwell Molecular Holdings LLC)
Accuretic, Tablet, 10 mg/12.5 mg (Pfizer Inc.)
NDC Code: 0071-0222-23Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Reason for shortage: Delay in shipping of the drug
Related Information: Next Delivery and Estimated Recovery: TBD
Therapeutic category: Cardiovascular
Initial posting date: January 19, 2023
Contact info: 800-533-4535
Accuretic, Tablet, 20 mg/12.5 mg (Pfizer Inc.)
NDC Code: 0071-0220-23Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Reason for shortage: Delay in shipping of the drug
Related Information: Next Delivery and Estimated Recovery: TBD
Therapeutic category: Cardiovascular
Initial posting date: January 19, 2023
Contact info: 800-533-4535
Accuretic, Tablet, 25 mg/20 mg (Pfizer Inc.)
NDC Code: 0071-0223-23Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Reason for shortage: Delay in shipping of the drug
Related Information: Next Delivery and Estimated Recovery: TBD
Therapeutic category: Cardiovascular
Initial posting date: January 19, 2023
Contact info: 800-533-4535
Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (Aurobindo Pharma USA)
NDC Code: 65862-161-90Availability: Discontinued
Status: Current
Date of update: June 25, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Therapeutic category: Cardiovascular
Initial posting date: January 19, 2023
Contact info: 866-850-2876
Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (Aurobindo Pharma USA)
NDC Code: 65862-162-90Availability: Discontinued
Status: Current
Date of update: June 25, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Therapeutic category: Cardiovascular
Initial posting date: January 19, 2023
Contact info: 866-850-2876
Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (Aurobindo Pharma USA)
NDC Code: 65862-163-90Availability: Discontinued
Status: Current
Date of update: June 25, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Therapeutic category: Cardiovascular
Initial posting date: January 19, 2023
Contact info: 866-850-2876
Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (Chartwell Molecular Holdings LLC)
NDC Code: 62135-667-90Availability: Available
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Therapeutic category: Cardiovascular
Initial posting date: January 19, 2023
Contact info: 845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com
Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (Chartwell Molecular Holdings LLC)
NDC Code: 62135-668-90Availability: Available
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Therapeutic category: Cardiovascular
Initial posting date: January 19, 2023
Contact info: 845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com
Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (Chartwell Molecular Holdings LLC)
NDC Code: 62135-669-90Availability: Available
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Therapeutic category: Cardiovascular
Initial posting date: January 19, 2023
Contact info: 845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.